Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

Phillips TM, McBride WH, Pajonk F.

J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85.

PMID:
17179479
2.

Senescence evasion by MCF-7 human breast tumor-initiating cells.

Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M.

Breast Cancer Res. 2010;12(3):R31. doi: 10.1186/bcr2583. Epub 2010 Jun 2.

3.

STAT1 promotes radioresistance of CD44(+)/CD24(-/low) cells in breast cancer.

Zhan JF, Chen LH, Yuan YW, Xie GZ, Sun AM, Liu Y, Chen ZX.

Exp Biol Med (Maywood). 2011 Apr 1;236(4):418-22. doi: 10.1258/ebm.2011.010287. Epub 2011 Mar 28.

PMID:
21444368
4.

HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.

So JY, Wahler J, Das Gupta S, Salerno DM, Maehr H, Uskokovic M, Suh N.

J Steroid Biochem Mol Biol. 2015 Apr;148:111-21. doi: 10.1016/j.jsbmb.2014.12.013. Epub 2014 Dec 23.

5.

[Influence factors on the formation of mammospheres from breast cancer stem cells].

Huang MZ, Zhang FC, Zhang YY.

Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):500-4. Chinese.

6.

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.

Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.

J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. doi: 10.1093/jnci/djq361. Epub 2010 Oct 8.

7.

Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.

Rappa G, Lorico A.

Exp Cell Res. 2010 May 15;316(9):1576-86. doi: 10.1016/j.yexcr.2010.01.012. Epub 2010 Jan 11.

8.

A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells.

Sharma A, Paranjape AN, Rangarajan A, Dighe RR.

Mol Cancer Ther. 2012 Jan;11(1):77-86. doi: 10.1158/1535-7163.MCT-11-0508. Epub 2011 Nov 10.

9.

HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Duru N, Fan M, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, Li S, Spitz DR, Lam KS, Wicha MS, Li JJ.

Clin Cancer Res. 2012 Dec 15;18(24):6634-47. doi: 10.1158/1078-0432.CCR-12-1436. Epub 2012 Oct 22.

10.

[Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].

Lu ZH, Jia J, Ren J, Ma B, DI LJ, Song GH.

Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):480-5. Chinese.

11.

TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.

Storci G, Sansone P, Mari S, D'Uva G, Tavolari S, Guarnieri T, Taffurelli M, Ceccarelli C, Santini D, Chieco P, Marcu KB, Bonafè M.

J Cell Physiol. 2010 Nov;225(3):682-91. doi: 10.1002/jcp.22264.

12.

[Dendritic cells infected by recombinant adeno-associated virus with CEA gene to induce antigen-specific CTL response to CD44(+)CD24(-/low) cells from MCF-7 breast cancer cell line].

Wang XL, Ma B, Jia J, Yuan YH, Yan Y, Di LJ, Song GH, Yu J, Ren J.

Beijing Da Xue Xue Bao. 2011 Apr 18;43(2):173-8. Chinese.

13.

Radiation-induced Notch signaling in breast cancer stem cells.

Lagadec C, Vlashi E, Alhiyari Y, Phillips TM, Bochkur Dratver M, Pajonk F.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):609-18. doi: 10.1016/j.ijrobp.2013.06.2064. Epub 2013 Aug 27.

14.

MicroRNA expression analysis of mammospheres cultured from human breast cancers.

Feifei N, Mingzhi Z, Yanyun Z, Huanle Z, Fang R, Mingzhu H, Mingzhi C, Yafei S, Fengchun Z.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1937-44. doi: 10.1007/s00432-012-1272-5. Epub 2012 Jul 3.

PMID:
22752669
15.

Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.

Mine T, Matsueda S, Li Y, Tokumitsu H, Gao H, Danes C, Wong KK, Wang X, Ferrone S, Ioannides CG.

Cancer Immunol Immunother. 2009 Aug;58(8):1185-94. doi: 10.1007/s00262-008-0623-1. Epub 2008 Dec 2.

16.

SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.

Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R Jr, Badve S, Srour EF, Nakshatri H.

BMC Cancer. 2010 Aug 6;10:411. doi: 10.1186/1471-2407-10-411.

17.

[Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].

Peng L, Li FX, Shao WF, Xiong JB.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Oct;33(10):1421-6. Chinese.

18.

Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties.

Ghiabi P, Jiang J, Pasquier J, Maleki M, Abu-Kaoud N, Rafii S, Rafii A.

PLoS One. 2014 Nov 7;9(11):e112424. doi: 10.1371/journal.pone.0112424. eCollection 2014.

19.

Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.

Ahmadipour F, Noordin MI, Mohan S, Arya A, Paydar M, Looi CY, Keong YS, Siyamak EN, Fani S, Firoozi M, Yong CL, Sukari MA, Kamalidehghan B.

Drug Des Devel Ther. 2015 Feb 24;9:1193-208. doi: 10.2147/DDDT.S72127. eCollection 2015.

20.

Mammary stem cells and breast cancer--role of Notch signalling.

Farnie G, Clarke RB.

Stem Cell Rev. 2007 Jun;3(2):169-75. Review.

PMID:
17873349

Supplemental Content

Support Center